Company intelligence / Profile preview

ProShares

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

ProShares is a major issuer of exchange-traded funds (ETFs), including leveraged and inverse ETFs across a range of sectors, but is not a drug development or biotech company itself. Some of its funds, such as ProShares Ultra Nasdaq Biotechnology, provide exposure to listed biotech and pharma companies, but ProShares is not itself a developer of drugs or healthcare products.[5][2][4]

Industry: Investors

Beyond the preview

Go deeper on ProShares.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProShares.

Explore the full profile